KUALA LUMPUR, Feb 9 -- Adagene Inc (Adagene) announced that members of the company’s management will participate in one-on-one investor meetings and provide a corporate update at the SVB Leerink 11th Annual Global Healthcare Conference, to be held virtually Feb 14-18, 2022.
The presentation is scheduled on Feb 17 at 11.20am (ET). A webcast of the presentation will be accessible in the Investors section of the company’s website for at least 30 days, according to a statement.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.
Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs.
More details at https://www.adagene.com.
-- BERNAMA
No comments:
Post a Comment